Anbio Biotechnology Class A Ordinary Shares (NNNN) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $5.55 (-0.89%), Market cap $1.18B, P/E ratio 179.60, 52-week low–high $7.54 ~ $52.10.
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Financial statements, price targets, institutional (13F) holdings and related news for Anbio Biotechnology Class A Ordinary Shares are updated in real time on BlackAll Trade.
Anbio Biotechnology Class A Ordinary Shares trades at $5.55 (-0.89%). Real-time quotes and charts are available on BlackAll Trade.
Anbio Biotechnology Class A Ordinary Shares has a market cap of about $1.18B. Its P/E ratio is 179.60.
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay